These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 28917248)
1. Stereotactic body radiation therapy for prostate cancer-a review. Haque W; Butler EB; Teh BS Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S10. PubMed ID: 28917248 [TBL] [Abstract][Full Text] [Related]
2. Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer. Halpern JA; Sedrakyan A; Hsu WC; Mao J; Daskivich TJ; Nguyen PL; Golden EB; Kang J; Hu JC Cancer; 2016 Aug; 122(16):2496-504. PubMed ID: 27224858 [TBL] [Abstract][Full Text] [Related]
3. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer. Kole TP; Nichols RC; Lei S; Wu B; Huh SN; Morris CG; Lee S; Tong M; Mendenhall NP; Dritschilo A; Collins SP Acta Oncol; 2015 Jun; 54(6):825-31. PubMed ID: 25227898 [TBL] [Abstract][Full Text] [Related]
4. What is the best way to radiate the prostate in 2016? Moon DH; Efstathiou JA; Chen RC Urol Oncol; 2017 Feb; 35(2):59-68. PubMed ID: 27395453 [TBL] [Abstract][Full Text] [Related]
5. Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa). Peyraga G; Lizee T; Khalifa J; Blais E; Mauriange-Turpin G; Supiot S; Krhili S; Tremolieres P; Graff-Cailleaud P Cancer Radiother; 2021 Jun; 25(4):400-409. PubMed ID: 33478838 [TBL] [Abstract][Full Text] [Related]
6. A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer. Oermann EK; Slack RS; Hanscom HN; Lei S; Suy S; Park HU; Kim JS; Sherer BA; Collins BT; Satinsky AN; Harter KW; Batipps GP; Constantinople NL; Dejter SW; Maxted WC; Regan JB; Pahira JJ; McGeagh KG; Jha RC; Dawson NA; Dritschilo A; Lynch JH; Collins SP Technol Cancer Res Treat; 2010 Oct; 9(5):453-62. PubMed ID: 20815416 [TBL] [Abstract][Full Text] [Related]
7. Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques. Dee EC; Muralidhar V; King MT; Martin NE; D'Amico AV; Mouw KW; Orio PF; Nguyen PL; Leeman JE Radiother Oncol; 2021 Aug; 161():241-250. PubMed ID: 34171451 [TBL] [Abstract][Full Text] [Related]
8. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288 [TBL] [Abstract][Full Text] [Related]
10. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer. Pan HY; Jiang J; Hoffman KE; Tang C; Choi SL; Nguyen QN; Frank SJ; Anscher MS; Shih YT; Smith BD J Clin Oncol; 2018 Jun; 36(18):1823-1830. PubMed ID: 29561693 [TBL] [Abstract][Full Text] [Related]
11. The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer-Quo Vadimus? Ong WL; Loblaw A World J Urol; 2023 Dec; 41(12):3485-3491. PubMed ID: 37921936 [TBL] [Abstract][Full Text] [Related]
12. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy. Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605 [TBL] [Abstract][Full Text] [Related]
13. Is robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected]. Zaorsky NG; Hurwitz MD; Dicker AP; Showalter TN; Den RB Expert Rev Med Devices; 2015 May; 12(3):317-27. PubMed ID: 25540018 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer. Vu CC; Blas KG; Lanni TB; Gustafson GS; Krauss DJ Brachytherapy; 2018; 17(6):852-857. PubMed ID: 30076108 [TBL] [Abstract][Full Text] [Related]
15. Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer. Royce TJ; Mavroidis P; Wang K; Falchook AD; Sheets NC; Fuller DB; Collins SP; El Naqa I; Song DY; Ding GX; Nahum AE; Jackson A; Grimm J; Yorke E; Chen RC Int J Radiat Oncol Biol Phys; 2021 May; 110(1):227-236. PubMed ID: 32900561 [TBL] [Abstract][Full Text] [Related]
16. Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer. Shaverdian N; Verruttipong D; Wang PC; Kishan AU; Demanes DJ; McCloskey S; Kupelian P; Steinberg ML; King CR Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):516-525. PubMed ID: 28126301 [TBL] [Abstract][Full Text] [Related]
17. Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer. Johnson SB; Soulos PR; Shafman TD; Mantz CA; Dosoretz AP; Ross R; Finkelstein SE; Collins SP; Suy S; Brower JV; Ritter MA; King CR; Kupelian PA; Horwitz EM; Pollack A; Abramowitz MC; Hallman MA; Faria S; Gross CP; Yu JB Radiother Oncol; 2016 Nov; 121(2):294-298. PubMed ID: 27890426 [TBL] [Abstract][Full Text] [Related]
18. Advances in Radiotherapy for Prostate Cancer Treatment. Podder TK; Fredman ET; Ellis RJ Adv Exp Med Biol; 2018; 1096():31-47. PubMed ID: 30324346 [TBL] [Abstract][Full Text] [Related]
19. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241 [TBL] [Abstract][Full Text] [Related]